secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001493152-25-012560
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech appoints Seth Yon as CEO; Nixon remains Executive Chairman
-------------------------------------------------------------------------

- Seth Yon promoted from President/Chief Commercial Officer to President/CEO and director, effective Sept 15, 2025.
- Ron Nixon resigns as CEO but remains Executive Chairman; receives director retainer ($90K stock + $40K cash) plus $100K cash for Chairman role.
- Yon employment agreement: $600K base salary, up to 100% bonus/stock awards, plus $1M one-time restricted stock grant vesting over 3 years.
- Ashley Mackey designated principal accounting officer; Elizabeth Taylor remains CFO but no longer principal accounting officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315225012560/0001493152-25-012560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315225012560/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer